Header Logo

Connection

ANTHONY MARESSO to Bacteriophages

Back to Details
This is a "connection" page, showing publications ANTHONY MARESSO has written about Bacteriophages.
ANTHONY MARESSO
Connection Strength
8.065
Bacteriophages
  1. Results of TOR001: An open-label single patient study using targeted bacteriophage therapy for the treatment of chronic urinary tract infection. Int J Antimicrob Agents. 2025 Dec; 66(6):107613.
    View in: PubMed
    Score: 0.837
  2. Phage-induced protection against lethal bacterial reinfection. Proc Natl Acad Sci U S A. 2025 Jun 03; 122(22):e2423286122.
    View in: PubMed
    Score: 0.821
  3. Construction and characterization of DNA libraries from cultured phages and environmental viromes. Appl Environ Microbiol. 2024 10 23; 90(10):e0117124.
    View in: PubMed
    Score: 0.784
  4. The rise, fall, and resurgence of phage therapy for urinary tract infection. EcoSal Plus. 2024 Dec 12; 12(1):eesp00292023.
    View in: PubMed
    Score: 0.746
  5. A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes. Clin Infect Dis. 2023 10 13; 77(8):1079-1091.
    View in: PubMed
    Score: 0.734
  6. Class-Driven Synergy and Antagonism between a Pseudomonas Phage and Antibiotics. Infect Immun. 2023 08 16; 91(8):e0006523.
    View in: PubMed
    Score: 0.720
  7. Antiviral Resistance and Phage Counter Adaptation to Antibiotic-Resistant Extraintestinal Pathogenic Escherichia coli. mBio. 2021 04 27; 12(2).
    View in: PubMed
    Score: 0.619
  8. Targeting of Mammalian Glycans Enhances Phage Predation in the Gastrointestinal Tract. mBio. 2021 02 09; 12(1).
    View in: PubMed
    Score: 0.610
  9. Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry. mBio. 2020 08 04; 11(4).
    View in: PubMed
    Score: 0.588
  10. Bacteriophages from ExPEC Reservoirs Kill Pandemic Multidrug-Resistant Strains of Clonal Group ST131 in Animal Models of Bacteremia. Sci Rep. 2017 04 12; 7:46151.
    View in: PubMed
    Score: 0.467
  11. Bacteriophage-mediated reduction of uropathogenic E. coli from the urogenital epithelium. Infect Immun. 2026 Apr 15; 94(4):e0054325.
    View in: PubMed
    Score: 0.216
  12. Gene discovery from microbial gene libraries I: protection against reactive oxygen species-driven DNA damage. Microbiol Spectr. 2024 Nov 05; 12(11):e0036524.
    View in: PubMed
    Score: 0.196
  13. Appelmans protocol - A directed in vitro evolution enables induction and recombination of prophages with expanded host range. Virus Res. 2024 01 02; 339:199272.
    View in: PubMed
    Score: 0.185
  14. Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment. mSphere. 2022 08 31; 7(4):e0034522.
    View in: PubMed
    Score: 0.169
  15. Considerations for the Use of Phage Therapy in Clinical Practice. Antimicrob Agents Chemother. 2022 03 15; 66(3):e0207121.
    View in: PubMed
    Score: 0.163
  16. Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection. Viruses. 2021 10 12; 13(10).
    View in: PubMed
    Score: 0.160
  17. Present and future of microbiome-targeting therapeutics. J Clin Invest. 2025 Jun 02; 135(11).
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.